Xilio Therapeutics | ARS:年度报告
04/26 04:23
Xilio Therapeutics | DEFA14A:其他
04/26 04:16
Xilio Therapeutics | DEF 14A:股东委托书决议
04/26 04:09
Xilio Therapeutics | 424B5:募资说明书
04/15 21:04
Xilio Therapeutics | SC 13G:超过5%持股股东披露文件-Gilead Sciences, Inc.(19.9%)
04/06 04:36
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rock Springs Capital Management LP(8.71%),Rock Springs Capital LLC(8.71%)等
04/06 02:54
Xilio Therapeutics | 4:持股变动声明-股东 GILEAD SCIENCES, INC.
04/04 06:54
Xilio Therapeutics | 3:首次持股声明-股东 GILEAD SCIENCES, INC.
04/04 06:54
Xilio Therapeutics | S-8:员工福利计划证券登记
04/02 04:29
Xilio Therapeutics | 10-K:年度报表
04/02 04:27
Xilio Therapeutics | 8-K:Xilio Therapeutics公布管道和业务最新情况以及2023年第四季度和全年财务业绩
04/02 04:20
Xilio Therapeutics | 8-K:重大事件
03/29 04:17
Xilio Therapeutics | 8-K:重大事件
03/28 19:59
Xilio Therapeutics | SC 13G:超过5%持股股东披露文件-Rock Springs Capital Management LP(5.23%),Rock Springs Capital LLC(5.23%)
02/15 03:19
Xilio Therapeutics | 4:持股变动声明-股东 Atlas Venture Fund XI, L.P.
02/10 05:36
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(0%),OCTAGON INVESTMENTS MASTER FUND LP(0%)等
02/07 05:11
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(6.48%),OCTAGON INVESTMENTS MASTER FUND LP(6.48%)等
02/06 05:05
Xilio Therapeutics | 8-K:重大事件
01/19 13:00
Xilio Therapeutics | 4:持股变动声明-股东 Atlas Venture Fund XI, L.P.
01/16 13:00
Xilio Therapeutics | 4:持股变动声明-高管 Frankenfield Christopher James
01/03 13:00
暂无数据
暂无数据